Outcomes w/ mpMRI Compared to Diagnostic TURBT in Pts w/ Suspected Muscle-Invasive Bladder Cancer

Cancer
Nataliya Mar
Outcomes with Multi Parametric MRI (mpMRI) Compared to Diagnostic Transurethral Resection of Bladder Tumor (TURBT) in Patients with Suspected Muscle-Invasive Bladder Cancer - a Pilot Study
Urinary Bladder

Study Description

This is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging (mpMRI) compared to pathologic cancer stage obtained via diagnostic transurethral bladder tumor resection (TURBT) as well as compare the clinical and quality of life outcomes between these diagnostic modalities in patients with suspected muscle-invasive bladder cancer (MIBC).

Eligibility

You can participate in this study if you

  • Are 18 years of age or older
  • Have suspected muscle-invasive bladder cancer (MIBC) determined by cystoscopy

You cannot participate in this study if you

  • Have prior TURBT within 120 days
  • Have prior therapy for bladder cancer within 120 days
  • Unable to tolerate mpMRI or associated contrast
  • Unable to tolerate TURBT or associated anesthesia
  • Unable to comply with study procedures
  • Do not consent for study follow up via phone call
  • Are pregnant or breastfeeding
A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.